Related Experiment Video
Updated: May 22, 2025
07:18
Investigating Intestinal Barrier Breakdown in Living Organoids
Published on: March 26, 2020
10.9K
Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure
Julian Pohl1, Dimitrios Aretakis1, Frank Tacke1
1Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Seminars in Liver Disease
|March 13, 2025
Summary
Intestinal dysfunction significantly contributes to acute-on-chronic liver failure (ACLF), a severe liver condition. Targeting the gut-liver axis offers promising therapeutic strategies for ACLF management.
Area of Science:
- Hepatology
- Gastroenterology
- Microbiology
Background:
- Acute-on-chronic liver failure (ACLF) is a critical condition in decompensated cirrhosis with high mortality.
- Intestinal dysfunction is increasingly recognized as a key factor in ACLF development and progression.
Purpose of the Study:
- To review the role of the gut-liver axis in ACLF pathogenesis.
- To highlight recent advances and therapeutic strategies targeting the gut-liver axis in ACLF.
Main Methods:
- Literature review of experimental and clinical evidence.
- Discussion of key factors: gut barrier disruption, dysbiosis, and bacterial translocation.
- Exploration of therapeutic targets: FXR agonists, beta-blockers, antibiotics, and probiotics.
Main Results:
- Gut mucosal barrier disruption, gut dysbiosis, and bacterial translocation are central to systemic inflammation in ACLF.
- Therapeutic interventions targeting the gut-liver axis show potential for mitigating ACLF progression.
- Understanding ACLF pathophysiology distinct from other cirrhosis stages is crucial.
Conclusions:
- Disruption of intestinal integrity is integral to ACLF pathogenesis.
- Targeting the gut-liver axis presents novel diagnostic and therapeutic avenues for ACLF.
- Further research can lead to more effective management of this severe liver syndrome.
More Related Videos
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
106
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
106
01:24Chronic Pancreatitis I: Introduction
59
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
59
01:17Chronic Bowel Disorders: Introduction
375
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
375
01:14Hepatic Drug Clearance: Role of Transporters
31
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
31